Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Raphitoma

ABSTRACT: large scale genotyping of the neogastropod lineage Raphitoma (Conoidea)

PROVIDER: PRJNA1242061 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR32877700_1.fastq.gz	Fastqsanger.gz
	SRR32877700_2.fastq.gz	Fastqsanger.gz
	SRR32877701_1.fastq.gz	Fastqsanger.gz
	SRR32877701_2.fastq.gz	Fastqsanger.gz
	SRR32877702_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 160

Similar Datasets

Large Scale Genotyping of Psychiatric Disorders

Project description:Large Scale Genotyping of Psychiatric Disorders

| PRJNA394934 | ENA

Homo sapiens

Project description:Large Scale Genotyping of Psychiatric Disorders

| PRJNA394935 | ENA

Project description:SimGBS: A Rapid Method for Simulating Large-Scale Genotyping-by-Sequencing Data

| PRJEB54897 | ENA

18 PDX of triple-negative breast cancer genotyped with SNP6 Affymetrix arrays

Project description:To characterize Homologous recombination deficiency (BRCAness) in triple-negative breast cancer PDX models genomic signature was utilized. After normalization using Genotyping Console we obtained absolute copy number profiles using the GAP software (Popova et al, Genome Biol, 2009). The number of Large-scale State Transitions (LSTs) was used to annotate PDX as BRCAness or not (Popova et al, Cancer Res 2012).

2020-01-01 | E-MTAB-8654 | biostudies-arrayexpress

A generic, cost-effective and scalable cell lineage analysis platform

Project description:Advances in single-cell genomics enable commensurate improvements in methods for uncovering lineage relations among individual cells. Current sequencing based methods for cell lineage analysis depend on low resolution bulk analysis or rely on extensive single cell sequencing which is not scalable and could be biased by functional dependencies. Here we show an integrated biochemical-computational platform for generic single-cell lineage analysis that is retrospective, cost-effective and scalable. It consists of a biochemical-computational pipeline that inputs individual cells, produces targeted single-cell sequencing data and uses it to generate a lineage tree of the input cells. We validated the platform by applying it to cells sampled from an ex vivo grown tree and analyzed its feasibility landscape by computer simulations. We conclude that the platform may serve as a generic tool for lineage analysis and thus pave the way towards large-scale human cell lineage discovery.

2016-04-18 | E-MTAB-4553 | biostudies-arrayexpress

SMARCB1 maintains lineage fidelity in renal cancer - ATAC-seq

Project description:Transcriptional lineage factors are a prominent class of essential genes in cancer, but the mechanisms that maintain lineage fidelity in advanced cancer clones, and whether lineage factor pathways could be broadly exploited for cancer therapy remain poorly understood. Here, we have used clear cell renal cell carcinoma (ccRCC) as a model to characterise the mechanisms that underlie lineage factor dependence in cancer. Through CRISPR/Cas9 loss-of-function screening and functional validation we find that loss of SMARCB1, a member of the SWI/SNF chromatin remodelling complex, can confer an advantage to ccRCC cells upon inhibition of the essential renal lineage factor PAX8. PAX8 inhibition resistant cells formed tumours with a dramatically altered histology showing neuroendocrine differentiation. Based on ATAC-seq and RNA-seq analysis, SMARCB1 inactivation leads to large-scale loss of kidney-specific epigenetic programmes, acquisition of a cellular state resembling that of rhabdoid tumours, and eventual activation of proliferative pathways. We show that these pathways are supported by the adoption of new transcriptional dependencies on IRF2, BHLHE40, and ZNFX1, factors that represent rare essential genes across different lineage-specific and oncogenic pathways, a principle validated in a large-scale CRISPR/Cas9 screening data set comprising hundreds of cancer cell lines. Thus, lineage factor requirements in cancer can switch upon challenge. The rules governing such lineage switching should be considered when designing novel lineage factor-targeted cancer therapies.

2023-07-19 | GSE183353 | GEO

E-PROT-57

Project description:The Mount Sinai cohort of large-scale proteomic data in Alzheimer's disease

2021-05-20 | E-PROT-57 | ExpressionAtlas

Large-scale H3.1/H3.2 - H3K9me3 deposition defines the epigenetic signature of extraembryonic lineage cells

Project description:Large-scale H3.1/H3.2 - H3K9me3 deposition defines the epigenetic signature of extraembryonic lineage cells

| PRJNA733137 | ENA

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

Project description:Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

| PRJNA1057933 | ENA

Project description:Soil samples at large scale

| PRJNA1035420 | ENA